Skip to content

Search

Strong Beginnings

Focuses on understanding and improving early childhood health and development to set the foundation for lifelong wellbeing. By addressing factors from pregnancy through early years, this theme aims to optimise health outcomes from the very start.

First-hand fight inspires generous gift

A close call with meningococcal disease ignited a passion in Iain Buchan to do whatever he can to keep WA children safe from life-threatening infectious diseases.

Skin infections flying under the radar

The Kids Research Institute Australia researchers have confirmed that skin infections in many Aboriginal children across northern Western Australia are going unrecognised.

National guideline to tackle record rates of skin infection

Researchers have developed the first National Healthy Skin Guideline to address record rates of skin infections in Australia’s Indigenous communities.

Watershed approach to improve cystic fibrosis treatment

The Kids researchers are pioneering an exciting new approach to clinical trials, which aims to fast-track the best treatments for people with rare and complex diseases.

Important things you should know about this year’s flu season

News headlines about the large number of life-threatening cases of the flu in Western Australia this winter have been hard to miss - find out what you can do to protect your family.

Outstanding mentor named Eureka prize finalist

Leading infectious diseases researcher, Clinical Associate Professor Deborah Lehmann AO, has been named a finalist for the Australian Museum Eureka Prizes for her work training and mentoring a new generation of researchers.

Vaccination reminder program to boost immunisation rates across Australia

Families throughout the country will trial a new text message vaccination reminder program designed to safeguard kids against infectious diseases thanks to a generous funding boost from the Ramaciotti Foundation.

Latest RSV results pave way for world-first vaccine

The Kids Research Institute Australia researchers leading the Western Australian site of a global respiratory syncytial virus (RSV) study can now fine-tune development of a world-first vaccine for pregnant mothers.